Innovative Approach to Eliminating Alzheimer’s Brain Damage

Select Language:

Researchers have identified a promising new method that could eventually aid in treating Alzheimer’s disease by helping the brain eliminate harmful proteins. The study, conducted by scientists at the USC Stem Cell research center, centers on a natural internal cleaning process within brain cells rather than inhibiting critical brain chemicals. The findings were published in the journal Neuron.

Alzheimer’s is the leading cause of dementia, impacting millions globally. The disease gradually impairs memory, cognitive functions, and daily activities. While existing medications may temporarily alleviate symptoms for some, they do not halt the disease’s progression.

A key feature of Alzheimer’s is the buildup of abnormal proteins in the brain, notably tau. Excessive accumulation of damaged tau within nerve cells disrupts their normal operations, ultimately causing cell death and memory degradation. Scientists have also known that another chemical in the brain, glutamate, plays an important role. Glutamate is vital for learning, memory, and communication among brain cells, but excessive activity can induce harmful changes that promote toxic tau buildup.

Reducing glutamate levels isn’t a viable solution because it’s essential for proper brain function. Lowering it too much could cause serious side effects, including memory issues, movement problems, or even unconsciousness. Instead, researchers sought a safer way to shield brain cells.

To explore this, scientists studied tiny lab-grown brain organoids derived from human stem cells, created using cells from both healthy individuals and those with tau-related neurodegenerative conditions. They also conducted experiments on mice genetically predisposed to a form of dementia. When exposed to glutamate, these brain models showed a rapid buildup of toxic tau and increased nerve cell death, especially in tissue with disease-related changes. The team then analyzed gene activity during this process, identifying one gene, KCTD20, as playing a significant role.

By reducing KCTD20 activity, researchers observed promising results: tau buildup decreased sharply, and many nerve cells remained healthy despite glutamate exposure. Further studies revealed that inhibiting this gene activated lysosomes—small cellular structures that serve as waste disposal and recycling centers by breaking down unwanted material. These lysosomes surrounded and eliminated the toxic tau proteins, enhancing the brain’s natural cleanup system. Instead of preventing tau from forming, this approach facilitated the removal of harmful proteins before they could cause further damage.

Although this research is still in early stages and has not yet been tested in humans, it opens an exciting path for Alzheimer’s treatment development. Future drugs targeting KCTD20 or boosting lysosome activity could slow the disease’s progression without the side effects associated with altering glutamate levels.

For those interested in Alzheimer’s prevention, evidence suggests that unhealthy lifestyle choices can increase the risk of developing the disease, while strawberries may serve as a protective food. Other recent studies indicate that oral cannabis extracts might help reduce Alzheimer’s symptoms and that Vitamin E could play a role in preventing Parkinson’s disease.